Tag: INmune Bio
September 12, 2019
5 Alzheimer’s Disease Treatment Stocks on the NASDAQ
A report from Reports and Data suggests the overall Alzheimer's market will be worth US$12.43 billion by 2026. September 12, 2019
INmune Bio Gets US Patent for DN-TNFa Platform
INmune Bio (NASDAQ:INMB) has announced that the US Patent and Trademark Office has granted the company Patent Application Serial No.... May 15, 2019
INmune Bio Reports First Quarter 2019 Financial Results
INmune Bio (NASDAQ:INMB) has reported its financial results for the first quarter ended March 31, 2019. As quoted in the...
April 16, 2019